Literature DB >> 61878

Immunological properties of murine thymus-dependent lymphocyte surface glycoproteins.

I S Trowbridge, C Mazauskas.   

Abstract

The immunological properties of two murine thymus-dependent (T) lymphocyte surface glycoproteins, T200 and T25, were investigated. T200 is a lymphocyte-specific antigen with a high degree of species specificity. It shares antigenic determinants with molecules present on thymus-independent (B) lymphocytes. T25 has antigenic determinants which cross-react with antigens on mouse brain, rat thymocytes and rat brain. An antiserum against a purified rat brain glycoprotein which carries Thy-1.1 reacts with T25. Absorption of this antiserum with BALB/c thymocytes or brain homogenate produces a Thy-1.1 specific serum which reacts with T25 from AKR/J thymocytes but not with T25 from AKR/Cum thymocytes. These results confirm that T25 is the molecule on the surface of mouse T cells which carries the Thy-1 antigen. T25 also carries antigenic determinants, recognized by anti-thymocyte serum (ATS), which were found on secondary mouse embryo fibroblasts and untransformed fibroblast cell lines but which were not detected on fibroblast cell lines transformed with murine sarcoma virus (MSV) or with Simian virus 40 (SV40).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61878     DOI: 10.1002/eji.1830060806

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  MB1, a quail leukocyte-endothelium antigen: partial characterization of the cell surface and secreted forms in cultured endothelial cells.

Authors:  M C Labastie; T J Poole; B M Péault; N M Le Douarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 2.  Cell-surface-antigen mutants of haematopoietic cells. Tools to study differentiation, biosynthesis and function.

Authors:  R Hyman
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

3.  Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies.

Authors:  L Y Bourguignon; R Hyman; I Trowbridge; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Receptor specificity, functional characteristics, and cell-surface phenotype of a highly selected anti-I-Ab-specific, long-term T-cell line.

Authors:  B E Elliott; A Kimura; A B Peck; Z A Nagy; H Wigzell
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

5.  Two complementation classes of T200 (Ly-5) glycoprotein-negative mutants.

Authors:  R Hyman; I Trowbridge
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

6.  Isolation of plasma membrane domains from murine T lymphocytes.

Authors:  D C Hoessli; E Rungger-Brändle
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  The purification and characterization of a Thy-1-like glycoprotein from chicken brain.

Authors:  J A Rostas; T A Shevenan; C M Sinclair; P L Jeffrey
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

8.  Inhibition of Neisseria gonorrhoeae attachment to HeLa cells with monoclonal antibody directed against a protein II.

Authors:  R J Sugasawara; J G Cannon; W J Black; I Nachamkin; R L Sweet; G F Brooks
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45.

Authors:  L A Terry; M H Brown; P C Beverley
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

10.  Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

Authors:  Gabrielle A Rizzuto; Taha Merghoub; Daniel Hirschhorn-Cymerman; Cailian Liu; Alexander M Lesokhin; Diana Sahawneh; Hong Zhong; Katherine S Panageas; Miguel-Angel Perales; Grégoire Altan-Bonnet; Jedd D Wolchok; Alan N Houghton
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.